Merck & Co

Europe delays Merck & Co.'s HCV drug on back of CMO quality issues

Image: iStock/Nuno André

Inadequate record keeping at Merck & Co.’s contract manufacturer has delayed the European launch of its hepatitis C drug Zepatier (elbasvir and grazoprevir).

Image: Zinco79/istock

Merck expands deal with 'organ-on-chip' tech firm Emulate

Roche: Small molecule exit will lead to outsourcing opportunities

Roche: Small molecule exit will lead to outsourcing opportunities

CROs are expected to grow in size as they acquire smaller rivals and manufacturing capacity

Rush to acquire ex-pharma sites means survival of the biggest for CMOs

Aesica and Merck & Co. to benefit from green energy cost-savings in UK

Aesica and Merck & Co. to benefit from green energy cost-savings in UK

Bavarian Nordic's headquarters in Kvistgaard, Denmark

Bavarian Nordic wins up to $33m to develop J&J Ebola vaccine

Merck & CO. makes temozolomide on behalf of Sandoz

Merck recalls 276,000 pill bottles

Antiquated clinical trial industry ripe for change from innovation, experts say

Antiquated clinical trial industry ripe for change from innovation, experts say

TransCelerate CEO, leaders offer update on industry group’s activities

TransCelerate CEO, leaders offer update on industry group’s activities

Merck & Co. (MSD) is set to use Organovo's 3D printed human liver tissue in preclinical studies

Merck 'bio-inks' deal to use Organovo's 3D printed liver for preclinical studies

More Merck & Co